RCUS · Arcus Biosciences, Inc. · Executive Compensation
$25.83
+0.18 (+0.70%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$3.18B
Shares
127.33M
Volume · Sep 30
1.36M
Avg daily vol (3M)
1.32M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jennifer Jarrett | Chief Operating Officer | Resigned | 2026-03-23 |
| Dietmar Berger M.D., Ph.D. | Class II director | Appointed | 2025-02-06 |
| Richard Markus, M.D., Ph.D. | Chief Medical Officer | Appointed | 2025-01-21 |
| Johanna Mercier | Class II director | Appointed | 2024-01-30 |
| Jennifer Jarrett | Board | Resigned | 2024-01-30 |
| Juan Jaen, Ph.D. | Board | Resigned | 2024-01-30 |
| Alexander Azoy | Principal Accounting Officer | Appointed | 2023-03-10 |